Abstract
The present invention relates to inhibitors of tissue transglutaminase for use in the inhibition of angiogenesis in a subject. In particular, the invention provides compounds of Formula I for use in the treatment and/or prevention of angiogenic diseases and disorders of the eye, such as diabetic retinopathy and age-related macular degeneration (AMD). The invention further provides methods for inhibiting angiogenesis in a subject.
| Original language | English |
|---|---|
| Patent number | GB 1107576.9 |
| IPC | A61K38/05 |
| Publication status | Published - 6 May 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Dipeptide inhibitors of angiogenesis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver